Abstract
The aim of this paper is to descript the impact factors of HIV/AIDS patients’ quality of life (QOL) after antiretroviral therapy by reviewing cohort studies. We searched PubMed and EmBase databases from inception to September 2015 for primary cohort studies about HIV/AIDS patients’ QOL. Thirty cohort studies were enrolled in this review. Among the predictors, job stability and social support were mentioned as associating positively with QOL. IDU, symptoms, depressions, and higher viral loads associated negatively with QOL. The studies did not all achieve the same results, but none of the studies directly contradicted each other. To improve HAART benefits for HIV/AIDS patients, it is important to improve QOL predictors and weaken factors associated with decreased QOL, especially for female and older HIV/AIDS patients.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
